{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:04:42Z","timestamp":1780131882272,"version":"3.54.0"},"reference-count":28,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The authors previously published their experience with a multidisciplinary care pathway for the treatment of vision-threatening papilledema. Many of the patients in this series underwent optic nerve sheath fenestration (ONSF) using a medial upper eyelid approach to the optic nerve. The purpose of this study was to review the authors\u2019 experience with this surgical approach and to determine if it is a safe and effective treatment option for these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors reviewed all patients who underwent ONSF at their institution between 2014 and 2023. All charts were reviewed for any mention of serious intraoperative or postoperative complications for which patients had to undergo a subsequent neurosurgical procedure, either ventriculoperitoneal shunt placement or transverse venous sinus stenting. The authors analyzed visual acuity and visual field mean defect prior to surgery and at the first and most recent postoperative visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Fifty-two patients who underwent ONSF at our institution during this time were reviewed. None of these patients experienced serious complications from the surgery. Thirteen patients subsequently underwent ventriculoperitoneal shunting and 3 subsequently underwent transverse venous sinus stenting. Visual acuity did not change significantly from baseline to the first and most recent postoperative visits. Visual field mean defect significantly improved from baseline to the first and most recent postoperative visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>ONSF via medial upper eyelid crease incision is a safe and effective option as part of a multidisciplinary treatment protocol for the treatment of vision-threatening papilledema.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.11.focus25850","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T05:51:55Z","timestamp":1767246715000},"page":"E17","source":"Crossref","is-referenced-by-count":0,"title":["Medial upper eyelid crease incision approach to optic nerve sheath fenestration as part of a multidisciplinary treatment protocol for patients with vision-threatening papilledema"],"prefix":"10.3171","volume":"60","author":[{"given":"Alexandra","family":"Pietraszkiewicz","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Baugh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azraa","family":"Ayesha","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen B.","family":"Digre","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"},{"name":"Department of Neurology, University of Utah Health; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra C. K.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E. A.","family":"Warner","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"},{"name":"Department of Neurology, University of Utah Health; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan D.","family":"Seay","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"},{"name":"Department of Neurology, University of Utah Health; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison V.","family":"Crum","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"},{"name":"Department of Neurology, University of Utah Health; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravanthi","family":"Vegunta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"},{"name":"Department of Neurology, University of Utah Health; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P.","family":"Marx","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Codden","sequence":"additional","affiliation":[{"name":"Clinical and Translational Science Institute, Department of Internal Medicine, Division of Epidemiology, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Brintz","sequence":"additional","affiliation":[{"name":"Clinical and Translational Science Institute, Department of Internal Medicine, Division of Epidemiology, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Health;"},{"name":"Department of Neurology, University of Utah Health; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"3","key":"b1","series-title":"Neurology","first-page":"229","article-title":"Fulminant idiopathic intracranial hypertension","volume":"68","author":"Thambisetty M","year":"2007","unstructured":"Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68(3):229\u2013232. doi:10.1212\/01.wnl.0000251312.19452.ec"},{"issue":"10","key":"b2","series-title":"J Neurol Neurosurg Psychiatry","first-page":"1088","article-title":"Idiopathic intracranial hypertension: consensus guidelines on management","volume":"89","author":"Mollan SP","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC,  Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088\u20131100. doi:10.1136\/jnnp-2017-317440"},{"issue":"1","key":"b3","series-title":"Noro Psikiyatr Ars","first-page":"23","article-title":"Idiopathic intracranial hypertension: etiological factors, clinical features, and prognosis","volume":"57","author":"Keskin AO","year":"2020","unstructured":"Keskin AO, Idiman F, Kaya D, Bircan B. Idiopathic intracranial hypertension: etiological factors, clinical features, and prognosis. Noro Psikiyatr Ars. 2020;57(1):23\u201326."},{"issue":"4","key":"b4","series-title":"J Neuroophthalmol","first-page":"495","article-title":"Interdisciplinary protocol for the management of vision-threatening papilledema","volume":"42","author":"Brady T","year":"2022","unstructured":"Brady T, Vegunta S, Crum AV,  Interdisciplinary protocol for the management of vision-threatening papilledema. J Neuroophthalmol. 2022;42(4):495\u2013501. doi:10.1097\/WNO.0000000000001594"},{"issue":"4","key":"b5","series-title":"Ophthalmic Plast Reconstr Surg","first-page":"241","article-title":"Superomedial lid crease approach to the medial intraconal space: a new technique for access to the optic nerve and central space","volume":"17","author":"Pelton RW","year":"2001","unstructured":"Pelton RW, Patel BC. Superomedial lid crease approach to the medial intraconal space: a new technique for access to the optic nerve and central space. Ophthalmic Plast Reconstr Surg. 2001;17(4):241\u2013253. doi:10.1097\/00002341-200107000-00003"},{"issue":"2","key":"b6","series-title":"Neurol Clin","first-page":"433","article-title":"The pseudotumor cerebri syndrome","volume":"42","author":"Friedman DI","year":"2024","unstructured":"Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2024;42(2):433\u2013471. doi:10.1016\/j.ncl.2024.02.001"},{"issue":"2","key":"b7","series-title":"Neurosurg Rev","first-page":"773","article-title":"A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH)","volume":"44","author":"Kalyvas A","year":"2021","unstructured":"Kalyvas A, Neromyliotis E, Koutsarnakis C,  A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH). Neurosurg Rev. 2021;44(2):773\u2013792. doi:10.1007\/s10143-020-01288-1"},{"key":"b8","series-title":"StatPearls","article-title":"Optic nerve decompression","author":"Zeppieri M","year":"2025","unstructured":"Zeppieri M, Patel BC. Optic nerve decompression. In: StatPearls. StatPearls Publishing; 2025.Accessed November 19, 2025.https:\/\/pubmed.ncbi.nlm.nih.gov\/30855884\/"},{"issue":"2","key":"b9","series-title":"Ophthalmology","first-page":"412","article-title":"Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension","volume":"118","author":"Alsuhaibani AH","year":"2011","unstructured":"Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118(2):412\u2013414. doi:10.1016\/j.ophtha.2010.06.025"},{"issue":"5","key":"b10","series-title":"Eye (Lond)","first-page":"1418","article-title":"Optic nerve sheath fenestration via a supero-medial eyelid skin crease approach for the treatment of idiopathic intracranial hypertension in a UK population","volume":"35","author":"Jefferis JM","year":"2021","unstructured":"Jefferis JM, Littlewood RA, Pepper IM, Hickman SJ, Salvi SM. Optic nerve sheath fenestration via a supero-medial eyelid skin crease approach for the treatment of idiopathic intracranial hypertension in a UK population. Eye (Lond). 2021;35(5):1418\u20131426. doi:10.1038\/s41433-020-1024-8"},{"issue":"4","key":"b11","series-title":"Orbit","first-page":"413","article-title":"Outcomes of optic nerve sheath fenestration from superomedial eyelid crease approach","volume":"41","author":"Malik AI","year":"2022","unstructured":"Malik AI, Xu J, Lee AG. Outcomes of optic nerve sheath fenestration from superomedial eyelid crease approach. Orbit. 2022;41(4):413\u2013421. doi:10.1080\/01676830.2021.1880444"},{"issue":"1","key":"b12","series-title":"J Neuroophthalmol","first-page":"10","article-title":"Visual and pharmacotherapy outcomes after transverse sinus stenting for idiopathic intracranial hypertension","volume":"45","author":"Handzic A","year":"2025","unstructured":"Handzic A, Xie JS, Hendriks E,  Visual and pharmacotherapy outcomes after transverse sinus stenting for idiopathic intracranial hypertension. J Neuroophthalmol. 2025;45(1):10\u201316. doi:10.1097\/WNO.0000000000002156"},{"issue":"1","key":"b13","series-title":"Acta Neurochir (Wien)","first-page":"476","article-title":"Effectiveness of optic nerve sheath fenestration in preserving vision in idiopathic intracranial hypertension: an updated meta-analysis and systematic review","volume":"166","author":"Prokop K","year":"2024","unstructured":"Prokop K, Op\u0119chowska A, Sie\u015bkiewicz A, Lisowski \u0141, Mariak Z, \u0141yso\u0144 T. Effectiveness of optic nerve sheath fenestration in preserving vision in idiopathic intracranial hypertension: an updated meta-analysis and systematic review. Acta Neurochir (Wien). 2024;166(1):476. doi:10.1007\/s00701-024-06345-y"},{"issue":"6","key":"b14","series-title":"Invest Ophthalmol Vis Sci","first-page":"3850","article-title":"Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension","volume":"56","author":"Chen JJ","year":"2015","unstructured":"Chen JJ, Thurtell MJ, Longmuir RA,  Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci. 2015;56(6):3850\u20133859. doi:10.1167\/iovs.15-16450"},{"issue":"3","key":"b1","series-title":"Neurology","first-page":"229","article-title":"Fulminant idiopathic intracranial hypertension","volume":"68","author":"Thambisetty M","year":"2007","unstructured":"Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68(3):229\u2013232. doi:10.1212\/01.wnl.0000251312.19452.ec"},{"issue":"10","key":"b2","series-title":"J Neurol Neurosurg Psychiatry","first-page":"1088","article-title":"Idiopathic intracranial hypertension: consensus guidelines on management","volume":"89","author":"Mollan SP","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC,  Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088\u20131100. doi:10.1136\/jnnp-2017-317440"},{"issue":"1","key":"b3","series-title":"Noro Psikiyatr Ars","first-page":"23","article-title":"Idiopathic intracranial hypertension: etiological factors, clinical features, and prognosis","volume":"57","author":"Keskin AO","year":"2020","unstructured":"Keskin AO, Idiman F, Kaya D, Bircan B. Idiopathic intracranial hypertension: etiological factors, clinical features, and prognosis. Noro Psikiyatr Ars. 2020;57(1):23\u201326."},{"issue":"4","key":"b4","series-title":"J Neuroophthalmol","first-page":"495","article-title":"Interdisciplinary protocol for the management of vision-threatening papilledema","volume":"42","author":"Brady T","year":"2022","unstructured":"Brady T, Vegunta S, Crum AV,  Interdisciplinary protocol for the management of vision-threatening papilledema. J Neuroophthalmol. 2022;42(4):495\u2013501. doi:10.1097\/WNO.0000000000001594"},{"issue":"4","key":"b5","series-title":"Ophthalmic Plast Reconstr Surg","first-page":"241","article-title":"Superomedial lid crease approach to the medial intraconal space: a new technique for access to the optic nerve and central space","volume":"17","author":"Pelton RW","year":"2001","unstructured":"Pelton RW, Patel BC. Superomedial lid crease approach to the medial intraconal space: a new technique for access to the optic nerve and central space. Ophthalmic Plast Reconstr Surg. 2001;17(4):241\u2013253. doi:10.1097\/00002341-200107000-00003"},{"issue":"2","key":"b6","series-title":"Neurol Clin","first-page":"433","article-title":"The pseudotumor cerebri syndrome","volume":"42","author":"Friedman DI","year":"2024","unstructured":"Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2024;42(2):433\u2013471. doi:10.1016\/j.ncl.2024.02.001"},{"issue":"2","key":"b7","series-title":"Neurosurg Rev","first-page":"773","article-title":"A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH)","volume":"44","author":"Kalyvas A","year":"2021","unstructured":"Kalyvas A, Neromyliotis E, Koutsarnakis C,  A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH). Neurosurg Rev. 2021;44(2):773\u2013792. doi:10.1007\/s10143-020-01288-1"},{"key":"b8","series-title":"StatPearls","article-title":"Optic nerve decompression","author":"Zeppieri M","year":"2025","unstructured":"Zeppieri M, Patel BC. Optic nerve decompression. In: StatPearls. StatPearls Publishing; 2025.Accessed November 19, 2025.https:\/\/pubmed.ncbi.nlm.nih.gov\/30855884\/"},{"issue":"2","key":"b9","series-title":"Ophthalmology","first-page":"412","article-title":"Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension","volume":"118","author":"Alsuhaibani AH","year":"2011","unstructured":"Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118(2):412\u2013414. doi:10.1016\/j.ophtha.2010.06.025"},{"issue":"5","key":"b10","series-title":"Eye (Lond)","first-page":"1418","article-title":"Optic nerve sheath fenestration via a supero-medial eyelid skin crease approach for the treatment of idiopathic intracranial hypertension in a UK population","volume":"35","author":"Jefferis JM","year":"2021","unstructured":"Jefferis JM, Littlewood RA, Pepper IM, Hickman SJ, Salvi SM. Optic nerve sheath fenestration via a supero-medial eyelid skin crease approach for the treatment of idiopathic intracranial hypertension in a UK population. Eye (Lond). 2021;35(5):1418\u20131426. doi:10.1038\/s41433-020-1024-8"},{"issue":"4","key":"b11","series-title":"Orbit","first-page":"413","article-title":"Outcomes of optic nerve sheath fenestration from superomedial eyelid crease approach","volume":"41","author":"Malik AI","year":"2022","unstructured":"Malik AI, Xu J, Lee AG. Outcomes of optic nerve sheath fenestration from superomedial eyelid crease approach. Orbit. 2022;41(4):413\u2013421. doi:10.1080\/01676830.2021.1880444"},{"issue":"1","key":"b12","series-title":"J Neuroophthalmol","first-page":"10","article-title":"Visual and pharmacotherapy outcomes after transverse sinus stenting for idiopathic intracranial hypertension","volume":"45","author":"Handzic A","year":"2025","unstructured":"Handzic A, Xie JS, Hendriks E,  Visual and pharmacotherapy outcomes after transverse sinus stenting for idiopathic intracranial hypertension. J Neuroophthalmol. 2025;45(1):10\u201316. doi:10.1097\/WNO.0000000000002156"},{"issue":"1","key":"b13","series-title":"Acta Neurochir (Wien)","first-page":"476","article-title":"Effectiveness of optic nerve sheath fenestration in preserving vision in idiopathic intracranial hypertension: an updated meta-analysis and systematic review","volume":"166","author":"Prokop K","year":"2024","unstructured":"Prokop K, Op\u0119chowska A, Sie\u015bkiewicz A, Lisowski \u0141, Mariak Z, \u0141yso\u0144 T. Effectiveness of optic nerve sheath fenestration in preserving vision in idiopathic intracranial hypertension: an updated meta-analysis and systematic review. Acta Neurochir (Wien). 2024;166(1):476. doi:10.1007\/s00701-024-06345-y"},{"issue":"6","key":"b14","series-title":"Invest Ophthalmol Vis Sci","first-page":"3850","article-title":"Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension","volume":"56","author":"Chen JJ","year":"2015","unstructured":"Chen JJ, Thurtell MJ, Longmuir RA,  Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci. 2015;56(6):3850\u20133859. doi:10.1167\/iovs.15-16450"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/1\/article-pE17.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/1\/article-pE17.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/1\/article-pE17.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:39:11Z","timestamp":1780130351000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/1\/article-pE17.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":28,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2025.11.focus25850","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}